Przejdź do zawartości
Merck

Antiangiogenic potential of grape stem extract through inhibition of vascular endothelial growth factor expression.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (2015-01-03)
D Stagos, A Apostolou, E Poulios, E Kermeliotou, A Mpatzilioti, K Kreatsouli, S D Koulocheri, S A Haroutounian, D Kouretas
ABSTRAKT

The aim of the present study was to investigate the antiangiogenic potential of a grape stem extract against tube formation by human endothelial cells (EA.hy926). The results showed that at low and non-cytotoxic concentrations (50 and 100 μg/ml) the grape stem extract inhibited tube formation, indicating a possible antiangiogenic activity. Moreover, the results showed that this extract inhibited the expression levels of vascular endothelial growth factor (VEGF), one of the most potent proangiogenic factors, suggesting that the tube formation inhibition by the extract may be exerted through inhibition of VEGF levels. Since it is well established that VEGF prevents apoptosis, the previous finding was further supported by the fact that the grape stem extract induced apoptosis in EA.hy926 cells. Furthermore, it was shown that the extract treatment did not change the levels of the proangiogenic molecules hypoxia inducible factor 1 alpha (HIF-1α) and cyclooxygenase-1 (COX-1). Therefore, these findings indicate that the grape stem extract reduces VEGF levels through mechanisms that may be HIF-1α- and COX-1-independent. The present study is the first showing that grape stem extracts possess antiangiogenic potential. Thus, our findings suggest that since grape stem extracts possess important bioactivities such as antiangiogenic potential, they could be exploited for developing chemopreventive and anticancer agents, while simultaneously protecting the environment through the use of a harmful waste.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
(−)-Epicatechin, analytical standard
Epikatechina, primary reference standard
Sigma-Aldrich
Kaempferol, ≥97.0% (HPLC)
Sigma-Aldrich
Trypan Blue, ≥80% (HPLC), Dye content 60 %
Sigma-Aldrich
Cobalt(II) chloride, AnhydroBeads, −10 mesh, 99.9% trace metals basis
Sigma-Aldrich
(−)-Epicatechin, ≥98% (HPLC), from green tea
Sigma-Aldrich
Trypan Blue, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Kaempferol, ≥90% (HPLC), powder
Sigma-Aldrich
p-Coumaric acid, ≥98.0% (HPLC)
Supelco
Kaempferol, analytical standard
Sigma-Aldrich
Cobalt(II) chloride, AnhydroBeads, −10 mesh, 99.995% trace metals basis
Sigma-Aldrich
Quercetin, ≥95% (HPLC), solid
Sigma-Aldrich
(−)-Epicatechin, ≥90% (HPLC)
Sigma-Aldrich
Cobalt(II) chloride, purum p.a., anhydrous, ≥98.0% (KT)
Sigma-Aldrich
Cobalt(II) chloride, 97%
Supelco
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Kwercetyna, United States Pharmacopeia (USP) Reference Standard
Supelco
(+)-Catechin, analytical standard
Sigma-Aldrich
trans-Ferulic acid, ≥99%
Supelco
Gallic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
trans-Ferulic acid, 99%
Sigma-Aldrich
Trypan Blue solution, 0.4%, suitable for microscopy
Supelco
Caffeic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)
Supelco
trans-Ferulic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)
Sigma-Aldrich
Trypan Blue solution, 0.4%, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Gallic acid, 97.5-102.5% (titration)
Sigma-Aldrich
Caffeic acid, ≥98.0% (HPLC)
Supelco
trans-p-Coumaric acid, analytical standard
Sigma-Aldrich
Syringic acid, ≥95% (HPLC)
Supelco
Syringic acid, analytical standard